Clinical Trials Logo

Clinical Trial Summary

Chiari malformation corresponds to the herniation of cerebellar tonsils into the foramen magnum resulting in obstruction of cerebrospinal fluid circulation, which may eventually lead to the formation of an intramedullary cavity called syringomyelia. Chiari and syringomyelia can be responsible of variable symptoms, based on which neurosurgeons might propose surgical treatment. Yet, there is no properly developped and validated patient reported outcome measure (PROM) to assess the clinical severity of Chiari malformation and/or syringomyelia. The lack of such evaluation tool is a major issue to determine the optimal therapeutic strategy and to achieve a standardized and reproducible follow-up.


Clinical Trial Description

Chiari malformation corresponds to the herniation of cerebellar tonsils into the foramen magnum resulting in obstruction of cerebrospinal fluid circulation, which may eventually lead to the formation of an intramedullary cavity called syringomyelia. Chiari and syringomyelia can be responsible of variable symptoms, based on which neurosurgeons might propose surgical treatment. Yet, there is no properly developped and validated patient reported outcome measure (PROM) to assess the clinical severity of Chiari malformation and/or syringomyelia. The lack of such evaluation tool is a major issue to determine the optimal therapeutic strategy and to achieve a standardized and reproducible follow-up. The project will consist of two successive phases: a survey design of the questionnaire with small selected groups of patients; a monocentric pilot study on a limited population; The purpose of the development study is to produce a first version of the PROM based on proposed items written by experts and tested with volunteer patients (n = 10-20) within the framework of " focus groups" followed by cognitive debriefings. These items will explore various dimensions of the functional impact of Chiari malformation and syringomyelia (pain, motor disability, sphincter disorders, quality of life, etc.). The pilot study will test this 1st version of the questionnaire on a limited population of patients (n = 40) within the CRMR C-MAVEM of Bicêtre hospital to produce a final version. This work will be supplemented subsequently by a multicenter study allowing to validate a simple and reproducible evaluation tool in order to ensure the follow-up of patients with a Chiari malformation and/or syringomyelia and to measure surgical outcome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06011226
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Steven KNAFO, MD
Phone 01 45 21 22 88
Email steven.knafo@aphp.fr
Status Not yet recruiting
Phase
Start date September 2023
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06308367 - The Therapeutic Effect of Betaine in Syringomyelia Phase 2
Completed NCT00004738 - Genetic Analysis of the Chiari I Malformation
Completed NCT04220541 - Investigation of the Effects of Exercise on Patients With Chiari Malformation N/A
Completed NCT00001327 - Establishing the Physiology of Syringomyelia N/A
Completed NCT00011245 - Study and Surgical Treatment of Syringomyelia N/A
Completed NCT02341950 - Clinical Trial of a Serious Game for Individuals With SCI/D N/A
Recruiting NCT06268093 - The Therapeutic Effect of Thalidomide in Syringomyelia Phase 2
Not yet recruiting NCT05646810 - Impact of Peripheral Afferent Input on Central Neuropathic Pain N/A
Active, not recruiting NCT01150708 - A Prospective Natural History Study of Patients With Syringomyelia
Recruiting NCT06375759 - Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia N/A
Completed NCT02669836 - Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia N/A